Pharmaceuticals

Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

  • ALL984
  • 0 Pages
  • July 2014
  • Pharmaceuticals

Biosimilars or follow-on-biologics are the “copied” version of reference biologics, which are protected by intellectual rights that will expire soon. Patent expiration is the major driving factor of the biosimilars market. Most of the blockbuster patents will expire by the end of 2014, which would provide a competitive edge to local pharmaceutical manufacturers over the global players. For instance, patents for insulin glargine will expire by the end of this year, which would give an opportunity for the growth of insulin biosimilars market. Global biosimilars/follow-on-biologics market accounted for $1,358 million in 2013 and it is anticipated to generate $35,032 million by 2020, growing at a CAGR of 60.8% from 2014 to 2020.



Regulations for biosimilars plays a vital role in maintaining the viability and balance between original and biosimilar products. Various regulatory authorities, namely EMA and the U.S. FDA are actively regulating the biosimilars market. Regulations in the European union are considered benchmark around the world, as the guidelines proposed are most stringent for validation and commercialization of biosimilars. High profitability is the attractive aspect that is enticing companies to invest in the biosimilars industry. 



Geographically, Biosimilars market is segmented into North America, Europe, Asia-Pacific and LAMEA. Due to favorable regulatory policies designed by the European Medical Association, the European market has been maximizing on the biosimilars market. Asia-Pacific and LAMEA market would witness a substantial rise in the use of biosimilars, as the demand for cost effective treatment is growing due to the prevalence of chronic diseases. Collaboration with local players would be a key opportunity that could be fully explored by the biosimilars manufacturers in developing economies. Many companies such as Amgen and Novartis are collaborating with Asian players to gain a foothold in the biopharmaceutical market. 



Europe was the first region to draft guidelines for approval of biosimilars in 2006. Nevertheless, in 2008, the first biosimilars version of Granulocyte colony-stimulating factor (G-CSF) was introduced in the European Union under the regulatory guidance of European Medical Association (EMA). Currently, there are three biosimilar versions of G-CSF available in the European market, namely Ratiograstim/Tevagrastim/Biograstim, Zarzio/Filgrastim Hexal and Nivestim/Pliva/Mayne filgrastim. Adding to the G-CSF biosimilars, the insulin biosimilars also showcase tremendous potential in the future. 



Key Benefits




  • The study is segmented in a strategic divisions to gain deeper insights into the market dynamics and understand the competitive environment of the overall market 

  • Financial market forecast is provided for the next eight years by considering 2013 as the base year

  • Comprehensive and quantitative data about changing market trends, intensifying competition and opportunities in biosimilars market are provided to make better business decisions

  • Porter’s Five Forces model and SWOT analysis of the overall market is provided to help stakeholders gain strategic insights of the market

  • Deep dive analysis of key market players and strategies adopted by them are expounded to provide valuable information on the top contenders in the market

  • Identification of key investment pockets for the biosimilars market is strategically dealt to assist the stakeholders 



Key Deliverables



Global biosimilars/follow-on-biologics market is categorized into technology, product types, applications, services and geography.



MARKET BY TECHNOLOGY




  • Monoclonal Antibodies (MAb) Technology

  • Recombinant DNA Technology (rDNA technology)

  • Nuclear magnetic resonance (NMR) technology

  • Chromatography

  • Electrophoresis

  • Mass Spectrometry

  • Western Blotting

  • Bioassay



MARKET BY TYPES




  • Recombinant Non-Glycosylated Protein


    • Human Growth Hormone

    • Insulin

    • Interferon

    • Granulocyte colony stimulating factor (G-CSF)

    • Others



  • Recombinant Glycosylated Protein

    • Erythropoietin

    • Monoclonal antibodies

    • Others



  • Peptides

    • Octreotide

    • Desmopressin

    • Cyclosporine

    • Calcitonin

    • Eptifibatide

    • LH-RH (Leuprolide)

    • Nesiritide

    • Teriparatide

    • Bivalirudin

    • Enfuvirtide

    • Glucagon





MARKET BY APPLICATIONS




  • Blood disorders


    • Chemotherapy induce Anaemia

    • Hemophilia

    • Pulmonary embolism



  • Oncology diseases

    • Lungs cancer

    • Colorectal cancer

    • Breast cancer

    • Cervical cancer

    • Leukemia

    • Prostate cancer



  • Chronic and autoimmune diseases

    • Neutropenia

    • Multiple sclerosis

    • Cystic Fibrosis

    • Rheumatoid arthritis (RA)

    • Acromegaly

    • Leprosy



  • Growth hormone deficiencies

  • Others



MARKET BY SERVICES




  • Contract Research and Manufacturing Services (CRAMS)

  • Clinical Trials



MARKET BY GEOGRAPHY




  • North America

  • Europe

  • Asia-Pacific

  • LAMEA


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Hemoglobinopathies Market (Pipeline Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules, particularly defective globin chains. Hemoglobinopathies are inherited single-gene disorders of which sickle cell disease is the most common ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Hemophilia Treatment Market (Type, Medicine and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Hemophilia is a hereditary genetic disorder which impairs body ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995

Read More >>

Global Antipsychotic Drugs Market (Brand, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Macular Edema and Macular Degeneration Market (Types, treatment and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Macular edema is a condition in which the retinal layers around the fovea is accumulated by the fluid that leads to the vision impairment and also might lead to the vision loss. Macular edema can be of two types, namely cystoid macular edema and diabetic macular edema.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>